Edition:
United Kingdom

Intec Pharma Ltd (NTEC.OQ)

NTEC.OQ on NASDAQ Stock Exchange Capital Market

4.10USD
15 Aug 2018
Change (% chg)

$-0.20 (-4.65%)
Prev Close
$4.30
Open
$4.25
Day's High
$4.25
Day's Low
$3.90
Volume
25,638
Avg. Vol
33,376
52-wk High
$9.80
52-wk Low
$3.90

Revenue & Earnings Per Share

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Sep-18 4 0.00 0.00 0.00 --
Quarter Ending Dec-18 4 0.00 0.00 0.00 --
Year Ending Dec-18 4 0.00 0.00 0.00 0.00
Year Ending Dec-19 5 0.00 0.00 0.00 22.22
Earnings (per share)
Quarter Ending Sep-18 5 -0.33 -0.25 -0.42 --
Quarter Ending Dec-18 5 -0.34 -0.28 -0.42 --
Year Ending Dec-18 5 -1.42 -1.15 -1.68 -0.83
Year Ending Dec-19 5 -1.20 -0.84 -1.67 -0.69
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 97.68 30.58
P/E High - Last 5 Yrs. -- 268.23 47.03
P/E Low - Last 5 Yrs. -- 94.02 24.81
Beta -- 0.78 0.85
Price to Sales (TTM) -- 260.36 8.15
Price to Book (MRQ) -- 12.82 3.78
Price to Tangible Book (MRQ) -- 22.44 5.88
Price to Cash Flow (TTM) -- 63.78 21.39
% Owned Institutions -- 0.00 0.00

Dividends

  Company industry sector
Dividend Yield -- 0.38 1.79
Dividend Yield - 5 Year Avg -- 0.22 1.46
Dividend 5 Year Growth Rate -- 2.53 -6.23
Payout Ratio(TTM) -- 6.41 46.83

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago -- 157.03 6.92
Sales (TTM) vs TTM 1 Yr. Ago -- 90.80 11.36
Sales - 5 Yr. Growth Rate -- 24.32 7.60
EPS (MRQ) vs Qtr. 1 Yr. Ago -- 89.71 18.25
EPS (TTM) vs TTM 1 Yr. Ago -- -- --
EPS - 5 Yr. Growth Rate -- 23.12 7.55
Capital Spending - 5 Yr. Growth Rate -- 36.76 7.84

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 1.73 2.53
Current Ratio (MRQ) -- 5.48 3.58
LT Debt to Equity (MRQ) -- 19.99 11.26
Total Debt to Equity (MRQ) -- 23.82 14.56
Interest Coverage (TTM) -- -186.21 31.06

Profitability Ratios

  Company industry sector
Gross Margin (TTM) -- 57.78 55.12
Gross Margin - 5 Yr. Avg. -- 52.39 53.21
EBITD Margin (TTM) -- -- --
EBITD - 5 Yr. Avg -- -190.28 15.77
Operating Margin (TTM) -- -1,115.09 -2.60
Operating Margin - 5 Yr. Avg. -- -203.67 10.94
Pre-Tax Margin (TTM) -- -998.61 -0.67
Pre-Tax Margin - 5 Yr. Avg. -- -204.68 11.11
Net Profit Margin (TTM) -- -989.76 -3.89
Net Profit Margin - 5 Yr. Avg. -- -202.39 7.47
Effective Tax Rate (TTM) -- 12.19 20.48
Effective Tax Rate - 5 Yr. Avg. -- 18.71 24.17

Efficiency

  Company industry sector
Revenue/Employee (TTM) -- 5,153,126 735,010,332
Net Income/Employee (TTM) -- -5,684,337 85,647,511
Receivable Turnover (TTM) -- 6.46 5.48
Inventory Turnover (TTM) -- 2.30 3.59
Asset Turnover (TTM) -- 0.43 0.85

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -- 2.05 10.23
Return on Assets - 5 Yr. Avg. -- 2.59 11.03
Return on Investment (TTM) -- 3.30 12.84
Return on Investment - 5 Yr. Avg. -- 2.09 14.24
Return on Equity (TTM) -- 2.30 15.02
Return on Equity - 5 Yr. Avg. -- -6.83 15.57
Note: Units in Millions of US Dollars

Performance for Intec Pharma Ltd

Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.